Vol 2 (December 2018): Therapeutic Radiology and Oncology

Review Article 
Is radiotherapy the missing link to enhancing the outcomes in non-small cell lung cancer patients treated with immunotherapy?
Ritchell van Dams, David Raben, Percy Lee
Therapeutic Radiology and Oncology  
2018;
2:
66  
Editorial 
Can prophylactic cranial irradiation of extensive-stage small cell lung cancer prolong survival?
Hideyuki Harada
Therapeutic Radiology and Oncology  
2018;
2:
65  
Letter to the Editor 
Adding to the debate on once-a-week versus once-every-3-weeks cisplatin dosing in concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Kumar Prabhash
Therapeutic Radiology and Oncology  
2018;
2:
64  
Meet the Professor 
Prof. Hiroyuki Nakamura: accelerator-based BNCT will be chosen as a primary therapy for early stage cancer
Tan-Lun Yu
Therapeutic Radiology and Oncology  
2018;
2:
63  
Editorial 
The role of pelvic radiotherapy in stage IV rectal cancer—still working in the dark!
Rob Glynne-Jones
Therapeutic Radiology and Oncology  
2018;
2:
62  
Letter to the Editor 
Radiotherapy plus hyperthermia is effective for painful bony metastases—optimal schedule unsettled
Mau-Shin Chi, Kai-Lin Yang, Kwan-Hwa Chi
Therapeutic Radiology and Oncology  
2018;
2:
61  
Technical Report 
Improving regional dose distribution while maintaining high delivery efficiency for hypofractionated whole breast radiotherapy
Lijun Ma, Andrew Hwang
Therapeutic Radiology and Oncology  
2018;
2:
60  
Meet the Professor 
Dr. Amanda E. Schwint: enjoy every step of the way and admit “there are always more questions than answers”
Teresa Lin
Therapeutic Radiology and Oncology  
2018;
2:
59